36.02
-0.08(-0.22%)
Currency In USD
| Previous Close | 36.1 |
| Open | 36.17 |
| Day High | 36.19 |
| Day Low | 35.67 |
| 52-Week High | 38 |
| 52-Week Low | 24.05 |
| Volume | 1.86M |
| Average Volume | 3.87M |
| Market Cap | 15.57B |
| PE | 15.73 |
| EPS | 2.29 |
| Moving Average 50 Days | 36.24 |
| Moving Average 200 Days | 33.46 |
| Change | -0.08 |
If you invested $1000 in Royalty Pharma plc (RPRX) since IPO date, it would be worth $892.69 as of October 09, 2025 at a share price of $36.02. Whereas If you bought $1000 worth of Royalty Pharma plc (RPRX) shares 3 years ago, it would be worth $947.4 as of October 09, 2025 at a share price of $36.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
GlobeNewswire Inc.
Sep 29, 2025 12:15 PM GMT
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director.
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
GlobeNewswire Inc.
Sep 19, 2025 8:25 PM GMT
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET. The webcast will b
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
GlobeNewswire Inc.
Sep 10, 2025 11:30 AM GMT
First of its kind report offers insight from over 110 biopharma executives into the benefits of royalties, current market dynamics and outlook for royalty market expansionRoyalties have become integral to biopharma’s diversified capital landscape dri